title: Intravenous ribavirin therapy for adenovirus gastroenteritis after bone marrow transplantation.
authors.affiliation: Department of Bone Marrow Transplantation, Hadassah University Hospital, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
authors.forename: J
authors.initials: J
authors.lastname: Kapelushnik
authors.forename: R
authors.initials: R
authors.lastname: Or
authors.forename: M
authors.initials: M
authors.lastname: Delukina
authors.forename: A
authors.initials: A
authors.lastname: Nagler
authors.forename: N
authors.initials: N
authors.lastname: Livni
authors.forename: D
authors.initials: D
authors.lastname: Engelhard
mesh_terms: D000258:Adenovirus Infections, Human / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D000260:Adenoviruses, Human / Q000276:immunology / Q000302:isolation & purification; D000914:Antibodies, Viral / Q000032:analysis / Q000276:immunology; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002675:Child, Preschool; D003106:Colon / Q000737:chemistry / Q000276:immunology / Q000473:pathology; D005759:Gastroenteritis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007150:Immunohistochemistry; D007275:Injections, Intravenous; D008297:Male; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use*; D014923:Wiskott-Aldrich Syndrome / Q000628:therapy
chemical_list: D000914:Antibodies, Viral; D000998:Antiviral Agents; D012254:Ribavirin